Renascience Inc.
Renascience Inc. scores highest on Torque (56) and lowest on Price (8). Its PosiPenta is 25.34 out of 100, weaker than most similar companies.
On the Penta Grid this week, Renascience Inc. is Grid #52 of 53 in the Healthcare sector in Japan, and Grid #1,037 of 1,059 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Renascience Inc. | 25.34 | 8 | 16 | 13 | 56 | 34 |
| Ohki Healthcare Holdings Co.,Ltd. | 46.77 | 69 | 50 | 24 | 29 | 61 |
| HYUGA PRIMARY CARE Co.,Ltd. | 56.04 | 17 | 65 | 100 | 56 | 43 |
| Japan Medical Dynamic Marketing, INC. | 36.57 | 47 | 53 | 24 | 25 | 34 |
| Fuso Pharmaceutical Industries,Ltd. | 66.50 | 95 | 91 | 50 | 34 | 64 |
| StemRIM | 28.11 | 27 | 23 | 6 | 54 | 31 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -40.81 |
| P/B ratio | 4.18 |
EEarnings
| Trailing EPS | ₹-14.58 |
| Forward EPS | — |
NNitro
| Price | 595.07 |
| 52-week high | 1348.75 |
| 52-week low | 563.59 |
| Fall from 52-week high | 55.9% |
TTorque
| Return on equity (ROE) | -12.96% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.71 |
| Market cap | ₹819 Cr |
| Insider holding | 56.99% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Renascience Inc.'s PosiPenta score?
Renascience Inc.'s PosiPenta is 25.34 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Renascience Inc. stand on the Penta Grid?
On the Penta Grid this week, Renascience Inc. is Grid #52 of 53 in the Healthcare sector in Japan, and Grid #1,037 of 1,059 in Japan.
Which PosiPenta pillar is strongest for Renascience Inc.?
Torque (durability), with a score of 56 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Renascience Inc.?
Price (valuation), with a score of 8 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.